Harbour Investments, Inc. Fulcrum Therapeutics, Inc. Transaction History
Harbour Investments, Inc.
- $3.14 Billion
- Q3 2024
A detailed history of Harbour Investments, Inc. transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Harbour Investments, Inc. holds 1,165 shares of FULC stock, worth $3,995. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,165
Previous 1,165
-0.0%
Holding current value
$3,995
Previous $7,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding FULC
# of Institutions
136Shares Held
58.8MCall Options Held
4.33MPut Options Held
309K-
Ra Capital Management, L.P. Boston, MA11.6MShares$39.8 Million1.08% of portfolio
-
Rtw Investments, LP New York, NY5.85MShares$20.1 Million0.61% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$16.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.07MShares$10.5 Million0.0% of portfolio
-
Cowen And Company, LLC2.96MShares$10.2 Million0.47% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $178M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...